Quantcast

Latest Sequenom Inc. Stories

2014-06-19 08:28:14

SOPHIA ANTIPOLIS, France, and SAN DIEGO, June 19, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, and Sequenom, Inc. (NASDAQ:SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that Nicox's subsidiary, Nicox Inc. is launching expanded access to Sequenom Laboratories' RetnaGene(TM) portfolio of laboratory-developed genetic tests in the United States (U.S.). The RetnaGene portfolio includes...

2014-06-19 08:25:52

LONDON, June 19, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Prenatal Testing Market in the US 2014-2018 http://www.reportbuyer.com/pharma_healthcare/diagnostics/prenatal_testing_market_us_2014_2018.html TechNavio's analysts forecast the Prenatal Testing market in the US to grow at a CAGR of 5.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of fetal health-related...

2014-06-16 08:28:27

SAN DIEGO, June 16, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, announced today that it has received premarket 510(k) clearance from the United States Food and Drug Administration (FDA) to market its IMPACT Dx(TM) Factor V Leiden and Factor II Genotyping Test and the IMPACT Dx(TM) System. The IMPACT Dx Factor V Leiden and Factor II Genotyping Test is performed on the IMPACT Dx System, and is indicated...

2014-06-16 08:28:21

MADISON, N.J. and SAN DIEGO, June 16, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, and Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced an agreement under which Quest will offer national access to Sequenom Laboratories' MaterniT21(TM) PLUS laboratory-developed test (LDT). Using a maternal blood sample, the noninvasive prenatal test (NIPT)...

2014-06-16 04:21:39

IMPACT Dx(TM) Combined Function System Will Also Be Available in the European Union SAN DIEGO, June 16, 2014 /PRNewswire/ -- Agena Bioscience, Inc., which recently acquired the Bioscience business of Sequenom, Inc., was notified today by Sequenom, Inc. that it received premarket clearance from the U.S. Food and Drug Administration (FDA) for the IMPACT Dx(TM) Factor V Leiden and Factor II Genotyping Test and the IMPACT Dx(TM) System. The IMPACT Dx(TM) Factor V Leiden and Factor II...

2014-06-09 08:28:07

SAN DIEGO, June 9, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, has signed a national agreement with a leading health insurance company covering 13 million people throughout the United States, to provide the MaterniT21(TM) PLUS laboratory-developed test (LDT). The addition of this contract brings the number of covered lives...

2014-06-04 12:29:57

Swiss Red Cross Study Recommends Replacing Kell, Kidd, Duffy Serotyping with Genotyping SAN DIEGO, June 4, 2014 /PRNewswire/ -- Agena Bioscience, Inc., which recently acquired the Bioscience business of Sequenom, Inc., today, introduced the Hemo ID((TM) )Blood Group Genotyping Panel for the MassARRAY(®) System following a Swiss Red Cross study using a beta version of the panel published in the journal Transfusion. The study, which genotyped and serotyped more than 4,000 blood donors...

2014-05-30 16:25:09

SAN DIEGO, May 30, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that it has completed the sale of its Bioscience business to Agena Bioscience, a portfolio company of Telegraph Hill Partners. The terms of the agreement provide for a purchase price of $31.8 million, subject to certain adjustments, and Sequenom may also receive up to $4 million in contingent consideration upon the...

2014-05-30 16:25:06

John Lillig to Lead Agena Bioscience as Chairman and Interim CEO SAN DIEGO, May 30, 2014 /PRNewswire/ -- Agena Bioscience, Inc., a portfolio company of Telegraph Hill Partners (THP), today acquired the Bioscience business of Sequenom, Inc. (NASDAQ: SQNM), which sells the MassARRAY® System for mass spectrometry-based detection of nucleic acids in research and clinical laboratories. Agena Bioscience has retained the employees of the acquired segment and will remain headquartered in...

2014-05-27 12:32:06

LONDON, May 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Non-Invasive Prenatal Testing (NIPT) Market (MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 -...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.